Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kan CWS"'
Autor:
Bouchet M; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France., Lainé A; University of Lyon-France.; Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France., Boyault C; Institute for Advanced Biosciences, UMR5209-INSERM1302, La Tronche, France., Proponnet-Guerault M; Institute for Advanced Biosciences, UMR5209-INSERM1302, La Tronche, France., Meugnier E; INSERMU1060-INRA-U1397, Lyon, France., Bouazza L; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France., Kan CWS; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France., Geraci S; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France., El-Moghrabi S; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France., Hernandez-Vargas H; Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France., Benetollo C; University of Lyon-France.; INSERM-UMR5292 INSERM U1028, Lyon, France., Yoshiko Y; Department of Calcified Tissue Biology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan., Duterque-Coquillaud M; University of Lille, Institut Pasteur de Lille, CNRS-UMR9020-INSERM-UMR1277, Lille, France., Clézardin P; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France., Marie JC; University of Lyon-France. edith.bonnelye@inserm.fr julien.marie@inserm.fr.; Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France., Bonnelye E; INSERM-UMR1033, Labex DEVweCAN, Lyon, France. edith.bonnelye@inserm.fr julien.marie@inserm.fr.; University of Lyon-France.
Publikováno v:
Cancer research [Cancer Res] 2020 Jul 01; Vol. 80 (13), pp. 2914-2926. Date of Electronic Publication: 2020 May 04.
Autor:
Croset M; INSERM, UMR_S1033, University Lyon 1, Lyon, France., Pantano F; INSERM, UMR_S1033, University Lyon 1, Lyon, France.; Medical Oncology Department, Campus Bio-Medico University of Rome, Rome, Italy., Kan CWS; INSERM, UMR_S1033, University Lyon 1, Lyon, France., Bonnelye E; INSERM, UMR_S1033, University Lyon 1, Lyon, France., Descotes F; Service de Biochimie Biologie Moléculaire, Hospices Civils de Lyon, Lyon, France., Alix-Panabières C; Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre, Montpellier, France., Lecellier CH; Université Montpellier 1, Montpellier, France., Bachelier R; INSERM, UMR_S1033, University Lyon 1, Lyon, France., Allioli N; Institut des Sciences Pharmaceutiques et Biologiques (ISPB)-Faculté de Pharmacie de Lyon, University Claude Bernard Lyon 1. Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Lyon, France., Hong SS; University Lyon 1, UMR 754-INRA-EPHE, Lyon, France., Bartkowiak K; Department of Tumor Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Pantel K; Department of Tumor Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Clézardin P; INSERM, UMR_S1033, University Lyon 1, Lyon, France. philippe.clezardin@inserm.fr.
Publikováno v:
Cancer research [Cancer Res] 2018 Sep 15; Vol. 78 (18), pp. 5259-5273. Date of Electronic Publication: 2018 Jul 24.